Skip to main content
NCBI home page
Scientific Reports logoLink to Scientific Reports
. 2023 Jan 26;13:1472. doi: 10.1038/s41598-023-28598-w

Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab

Kiyomi Kuba 1,✉, Hitoshi Inoue 1, Satoko Matsumura 1, Yuichiro Enoki 1, Yasunao Kogashiwa 1,#, Yasuhiro Ebihara 1,#, Mitsuhiko Nakahira 1,#, Tomoko Yamazaki 1,#, Masanari Yasuda 2, Kyoichi Kaira 3, Hiroshi Kagamu 3, Masashi Sugasawa 1,#
PMCID: PMC9879942  PMID: 36702866

Correction to: Scientific Reports 10.1038/s41598-022-27237-0, published online 29 December 2022

The original version of this Article contained an error in Table 3, where the values in row “Combined index of PD-L1 and tumoral CD8+TIL (1/2/3)” were swapped with the values in row “Combined index of PD-L1 and stromal CD8+TIL (1/2/3)” in columns “PFS” and “OS”. The correct and incorrect Tables appear below.

Incorrect:

Variables PFS OS
HR (95% Cl) P HR (95% Cl) P
Combined index of PD-L1 and tumoral CD8+TIL (1/2/3) 0.40 (0.20–0.77) 0.006 0.48 (0.24–0.95) 0.03
Combined index of PD-L1 and stromal CD8+TIL (1/2/3) 0.53 (0.28–1.00) 0.05 0.57 (0.29–1.13) 0.11
Open in a new tab

Correct:

Variables PFS OS
HR (95% Cl) P HR (95% Cl) P
Combined index of PD-L1 and tumoral CD8+TIL (1/2/3) 0.53 (0.28–1.00) 0.05 0.57 (0.29–1.13) 0.11
Combined index of PD-L1 and stromal CD8+TIL (1/2/3) 0.40 (0.20–0.77) 0.006 0.48 (0.24–0.95) 0.03
Open in a new tab

The original Article has been corrected.

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES